OnabotulinumtoxinA, approved by the US Food and Drug Administration (FDA) in 2013 to treat overactive bladder (OAB), may be an appropriate second-line treatment option for select patients with OAB, ...
A treatment best known for smoothing wrinkles is quietly changing lives for people living with overactive bladder, a condition that causes urgency, frequency, and incontinence. Overactive bladder (OAB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback